Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
about
Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Oral administration of a speci ...... ease in rat prefrontal cortex.
@en
Oral administration of a specific kynurenic acid synthesis
@nl
type
label
Oral administration of a speci ...... ease in rat prefrontal cortex.
@en
Oral administration of a specific kynurenic acid synthesis
@nl
prefLabel
Oral administration of a speci ...... ease in rat prefrontal cortex.
@en
Oral administration of a specific kynurenic acid synthesis
@nl
P2093
P2860
P1433
P1476
Oral administration of a speci ...... ease in rat prefrontal cortex.
@en
P2093
P2860
P356
10.1016/J.NEUROPHARM.2017.04.023
P577
2017-04-15T00:00:00Z